Although the human relevance of these findings remains uncertain, as human C-cells have lower GLP-1 receptor expression compared to rodents, the potential risk necessitates avoiding this medication in patients with any personal or family history of medullary thyroid carcinoma
Treatment with semaglutide tablets 14 mg once daily for 26 weeks resulted in non-inferior reductions in HbA1c compared to liraglutide 1.8 mg (see Table 7)
That can contribute to nausea, pressure, bloating, reflux, burping, or vomiting
While some users report weight loss success, many others cite issues with unexpected price increases and difficulty canceling subscriptions
Severe side effects and warnings While severe side effects are rare, both semaglutide and tirzepatide carry similar risks that are important to be aware of
Some U-100 syringes have different total capacities